Literature DB >> 12441312

Assessing menstrual cycles with urinary hormone assays.

N Santoro1, S L Crawford, J E Allsworth, E B Gold, G A Greendale, S Korenman, B L Lasley, D McConnell, P McGaffigan, R Midgely, M Schocken, M Sowers, G Weiss.   

Abstract

The Study of Women's Health Across the Nation (SWAN) is a multiethnic cohort study of middle-aged women enrolled at seven US sites. A subset of 848 women completed a substudy in which their urinary gonadotropins and sex steroid metabolites were assessed during one complete menstrual cycle or up to 50 consecutive days. Urine was analyzed for LH, FSH, estrone conjugates (E1c), and pregnanediol glucuronide (Pdg). To prepare for serial analysis of this large, longitudinal database in a population of reproductively aging women, we examined the performance of algorithms designed to identify features of the normal menstrual cycle in midreproductive life. Algorithms were based on existing methods and were compared with a "gold standard" of ratings of trained observers on a subset of 396 cycles from the first collection of Daily Hormone Substudy samples. In evaluating luteal status, overall agreement between and within raters was high. Only 17 of the 396 cycles evaluated were considered indeterminate. Of the 328 cycles rated as containing evidence of luteal activity (ELA), 320 were considered ELA by use of a Pdg threshold detection algorithm. Of 51 cycles that were rated as no evidence of luteal activity, only 2 were identified by this algorithm as ELA. Evaluation of the day of the luteal transition with methods that detected a change in the ratio of E1c to Pdg provided 85-92% agreement for day of the luteal transition within 3 days of the raters. Adding further conditions to the algorithm increased agreement only slightly, by 1-8%. We conclude that reliable, robust, and relatively simple objective methods of evaluation of the probability and timing of ovulation can be used with urinary hormonal assays in early perimenopausal women.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441312     DOI: 10.1152/ajpendo.00381.2002

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  34 in total

Review 1.  Menstrual Cycle Hormone Changes Associated with Reproductive Aging and How They May Relate to Symptoms.

Authors:  Amanda Allshouse; Jelena Pavlovic; Nanette Santoro
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

2.  Dehydroepiandrosterone sulfate levels reflect endogenous luteinizing hormone production and response to human chorionic gonadotropin challenge in older female macaque (Macaca fascicularis).

Authors:  Francisco M Moran; Jiangang Chen; Nancy A Gee; Pete N Lohstroh; Bill L Lasley
Journal:  Menopause       Date:  2013-03       Impact factor: 2.953

3.  Consistent ovulation may not be enough to make women healthy when approaching menopause: an update from the Study of Women's Health Across the Nation.

Authors:  Amanda A Allshouse; Alex Polotsky; Sybil Crawford; Hsiang-Yu Chen; Samar R El Khoudary; Nanette Santoro
Journal:  Menopause       Date:  2015-03       Impact factor: 2.953

4.  Menstrual Cycle Hormone Changes in Women Traversing Menopause: Study of Women's Health Across the Nation.

Authors:  Nanette Santoro; Sybil L Crawford; Samar R El Khoudary; Amanda A Allshouse; Sherri-Ann Burnett-Bowie; Joel Finkelstein; Carol Derby; Karen Matthews; Howard M Kravitz; Sioban D Harlow; Gail A Greendale; Ellen B Gold; Rasa Kazlauskaite; Dan McConnell; Genevieve Neal-Perry; Jelena Pavlovic; John Randolph; Gerson Weiss; Hsiang-Yu Chen; Bill Lasley
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

5.  Assessment of luteal function in the vervet monkey as a means to develop a model for obesity-related reproductive phenotype.

Authors:  Mila C Kundu; Margaret C May; Justin Chosich; Andrew P Bradford; Bill Lasley; Nancy Gee; Nanette Santoro; Susan E Appt; Alex J Polotsky
Journal:  Syst Biol Reprod Med       Date:  2013-01-02       Impact factor: 3.061

6.  Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles.

Authors:  Lauren Johnson; Mary D Sammel; Allison Schanne; Lara Lechtenberg; Maureen Prewitt; Clarisa Gracia
Journal:  Fertil Steril       Date:  2016-09-22       Impact factor: 7.329

7.  Vascular endothelial growth factor and breast cancer risk.

Authors:  Katherine W Reeves; Roberta B Ness; Roslyn A Stone; Joel L Weissfeld; Victor G Vogel; Robert W Powers; Francesmary Modugno; Jane A Cauley
Journal:  Cancer Causes Control       Date:  2008-11-06       Impact factor: 2.506

8.  Factors related to declining luteal function in women during the menopausal transition.

Authors:  N Santoro; S L Crawford; W L Lasley; J L Luborsky; K A Matthews; D McConnell; J F Randolph; E B Gold; G A Greendale; S G Korenman; L Powell; M F Sowers; G Weiss
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

9.  Partial recovery of luteal function after bariatric surgery in obese women.

Authors:  Dana Rochester; Akas Jain; Alex J Polotsky; Hanah Polotsky; Karen Gibbs; Barbara Isaac; Gohar Zeitlian; Cheryl Hickmon; Sophia Feng; Nanette Santoro
Journal:  Fertil Steril       Date:  2008-09-30       Impact factor: 7.329

10.  Cortisol levels and very early pregnancy loss in humans.

Authors:  Pablo A Nepomnaschy; Kathleen B Welch; Daniel S McConnell; Bobbi S Low; Beverly I Strassmann; Barry G England
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.